{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:03:06Z","timestamp":1784264586232,"version":"3.55.0"},"reference-count":45,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Objective: The course of relapsing\u2013remitting multiple sclerosis (RRMS) is highly variable and there is a lack of effective prognostic biomarkers. This study aimed to assess the potential prognostic value of the chemokines B lymphocyte chemoattractant molecule (CXCL13), eotaxin-1 (CCL11), and macrophage inflammatory protein 3-alpha (CCL20) in RRMS. Methods: Forty-two patients with MS were enrolled, along with 22 controls, 12 of the controls were idiopathic intracranial hypertension (IIH) patients, and 10 of the controls were other neurologic diseases (OND). Chemokine levels were measured using enzyme-linked immunosorbent assay (ELISA) in serum and cerebrospinal fluid (CSF) samples. Results: No significant differences were observed among the groups in serum levels of CXCL13, CCL11, and CCL20 (p = 0.509, p = 0.979, p = 0.169, respectively). CSF CXCL13 levels were significantly higher in the OND group (p = 0.016). A PATH analysis showed CSF CXCL13 was significantly associated with new T2 hyperintense lesions on brain magnetic resonance imaging (p &lt; 0.001), and baseline serum CCL11 levels were associated with EDSS (p = 0.030), implying its potential role in indicating neurodegenerative processes and possible progression risk. Serum CCL20 correlated with EDSS (p = 0.002) and lesion burden (p &lt; 0.001), reflecting disease severity. Conclusions: These findings suggest that CSF CXCL13 could serve as a useful biomarker for predicting active disease in RRMS, while follow-up serum CCL11 may assist in identifying progression. Although these chemokines are not specific to MS, higher levels may signal disease activity, severity, and transition to more progressive stages.<\/jats:p>","DOI":"10.3390\/biomedicines13010040","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T09:13:32Z","timestamp":1735290812000},"page":"40","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-7360","authenticated-orcid":false,"given":"I\u015f\u0131l","family":"Peker","sequence":"first","affiliation":[{"name":"Department of Neurology, Edirne Sultan 1. Murat State Hospital, 22030 Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-1710","authenticated-orcid":false,"given":"Hacer Ero\u011flu","family":"\u0130\u00e7li","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belgin","family":"Mutluay","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Y\u00fcksel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesrure","family":"K\u00f6seo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kanuni Sultan Suleiman Research and Training Hospital, 34303 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysu","family":"\u015een","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Atakl\u0131","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-5944","authenticated-orcid":false,"given":"Aysun","family":"Soysal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 34147 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.23758","article-title":"Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta","volume":"73","author":"Bermel","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5507\/bp.2023.002","article-title":"Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis","volume":"167","author":"Hradilek","year":"2023","journal-title":"Biomed. Pap."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"659206","DOI":"10.1155\/2014\/659206","article-title":"Chemokines and Chemokine Receptors in Multiple Sclerosis","volume":"2014","author":"Cheng","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Uzawa, A., Mori, M., Hayakawa, S., Masuda, S., Nomura, F., and Kuwabara, S. (2010). Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica. BMC Neurol., 10.","DOI":"10.1186\/1471-2377-10-113"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-5728(00)00456-2","article-title":"Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: Imbalance of Th1\/Th2-associated chemokine signaling","volume":"114","author":"Misu","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","article-title":"Sallusto FC-C chemokine receptor 6\u2013regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.4049\/jimmunol.0713169","article-title":"Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response","volume":"182","author":"Liston","year":"2009","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bai, Z., Chen, D., Wang, L., Zhao, Y., Liu, T., Yu, Y., Yan, T., and Cheng, Y. (2019). Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.01026"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/1352458509107017","article-title":"Serum levels of CXCL13 are elevated in active multiple sclerosis","volume":"15","author":"Festa","year":"2009","journal-title":"Mult. Scler. J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Brettschneider, J., Czerwoniak, A., Senel, M., Fang, L., Kassubek, J., Pinkhardt, E., Lauda, F., Kapfer, T., Jesse, S., and Lehmensiek, V. (2010). The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011986"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1006\/bbrc.1994.2734","article-title":"Eotaxin: Cloning of an Eosinophil Chemoattractant Cytokine and Increased mRNA Expression in Allergen-Challenged Guinea-Pig Lungs","volume":"205","author":"Jose","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1165\/rcmb.2007-0337OC","article-title":"Differential Regulation of Eotaxin Expression by Dexamethasone in Normal Human Lung Fibroblasts","volume":"38","author":"Suzuki","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2006.05.049","article-title":"Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis","volume":"247","author":"Franciotta","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tejera-Alhambra, M., Casrouge, A., de Andr\u00e9s, C., Seyfferth, A., Ramos-Medina, R., Alonso, B., Vega, J., Fern\u00e1ndez-Paredes, L., Albert, M.L., and S\u00e1nchez-Ram\u00f3n, S. (2015). Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128952"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","article-title":"The CC chemokine CCL20 and its receptor CCR6","volume":"14","author":"Schutyser","year":"2003","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.gene.2018.11.006","article-title":"The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt","volume":"685","author":"Ali","year":"2019","journal-title":"Gene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2010.09.026","article-title":"Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing\u2212remitting multiple sclerosis patients","volume":"300","author":"Pawlak","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jim.2003.09.018","article-title":"An ultrasensitive method for the detection of oligoclonal IgG bands","volume":"284","author":"Masjuan","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"ref_22","first-page":"234","article-title":"Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension","volume":"2","author":"Edwards","year":"2013","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1257085","DOI":"10.3389\/fimmu.2023.1257085","article-title":"Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus","volume":"14","author":"Lindblom","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar4552","article-title":"Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels","volume":"16","author":"Jones","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e200050","DOI":"10.1212\/NXI.0000000000200050","article-title":"Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis","volume":"10","author":"Fissolo","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12987-020-0170-5","article-title":"Chemokine CXCL13 in serum, CSF and blood\u2013CSF barrier function: Evidence of compartment restriction","volume":"17","author":"Pilz","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4172\/2155-9899.1000460","article-title":"Regulated Production of CXCL13 within the Central Nervous System","volume":"7","author":"Irani","year":"2016","journal-title":"J. Clin. Cell Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: A suggestive prognostic marker for the disease course","volume":"17","author":"Khademi","year":"2011","journal-title":"Mult. Scler. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/brain\/awh680","article-title":"Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment","volume":"129","author":"Krumbholz","year":"2006","journal-title":"Brain"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"\u015awiderek-Matysiak, M., Oset, M., Domowicz, M., Galazka, G., Namieci\u0144ska, M., and Stasio\u0142ek, M. (2023). Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020425"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid","volume":"49","author":"Bakels","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12987-015-0008-8","article-title":"The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis","volume":"12","author":"Dersch","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awaa250","article-title":"Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor","volume":"143","author":"Wagnon","year":"2020","journal-title":"Brain"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.12.014","article-title":"Key role of CXCL13\/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS","volume":"243","author":"Pranzatelli","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1073\/pnas.1211270110","article-title":"CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging","volume":"110","author":"Baruch","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/glia.22892","article-title":"CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia","volume":"63","author":"Parajuli","year":"2015","journal-title":"Glia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2016.09.010","article-title":"An emerging role for eotaxins in neurodegenerative disease","volume":"189","author":"Huber","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-019-1601-6","article-title":"Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases","volume":"16","author":"Lepennetier","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2017.10.013","article-title":"Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients","volume":"313","author":"Li","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12031-013-0214-2","article-title":"Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern","volume":"53","author":"Jafarzadeh","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2014.10.005","article-title":"The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1\/Th2\/Th17 convention","volume":"277","author":"Burman","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.14336\/AD.2018.0324","article-title":"Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept","volume":"10","author":"Chung","year":"2019","journal-title":"Aging Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hoefer, J., Luger, M., Dal-Pont, C., Culig, Z., Schennach, H., and Jochberger, S. (2017). The \u201cAging Factor\u201d Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor\u2019s Age. Front. Aging Neurosci., 9.","DOI":"10.3389\/fnagi.2017.00402"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat. Rev. Immunol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/1\/40\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:01:25Z","timestamp":1760115685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/1\/40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["biomedicines13010040"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13010040","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}